Early treatment of heart attack patients with an inexpensive beta-blocker drug called metoprolol, while in transit to the hospital, can significantly reduce damage to the heart during a myocardial infarction, according to clinical trial/study results published Oct. 1 in the journal Circulation. The study was a collaboration between Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) and Icahn School of Medicine at Mount Sinai.



As a cutting-edge technique, many hospitals around the country are investigating the development of their own TAVR programs. Starting a TAVR program requires a collaborative commitment to care and advanced imaging technology to plan and perform the exams. With the right approach and equipment, a TAVR program can have a profound impact on patients and the hospitals that serve them. 



The U.S. Food and Drug Administration (FDA) released a draft of its proposed updates for the non-clinical engineering tests and recommended labeling for intravascular stents and associated delivery systems. It is designed to provide draft guidance for industry and FDA staff.


Sudden cardiac death (SCD) is the leading cause of death in high school-aged athletes. To determine if SCD can be prevented with a heart screening, The Christ Hospital Health Network (Cincinnati, Ohio), The University of Mississippi Medical Center and Cincinnati Children’s Hospital Medical Center partnered with USRowing and Toshiba America Medical Systems Inc. to conduct The Athlete Heart Research Study. Initial participants included volunteer high school rowers with more than two years of continuous practice who competed in the USRowing Youth National Championships, June 7 – 9, 2013, in Oak Ridge, Tenn.

Methodist Le Bonheur Healthcare (MLH) will deploy McKesson’s portfolio of enterprise medical imaging products across its facilities to improve physician collaboration, streamline data management and simplify its imaging archive process with a single point of access.

Rochelle Community Hospital purchased and installed Carestream’s Vue Cardio PACS (picture archive and communications system) that provides fully featured viewing and management for its echo cardiograms and nuclear cardiology exams. This versatile system will also support ECGs and other types of cardiac exams that the critical access hospital may add in the future.

The U.S. Food and Drug Administration (FDA) approved Biotronik’s Ilesto family of implantable cardioverter-defibrillator/cardiac resynchronization therapy defibrillators (ICD/CRT-D devices). Biotronik follows this with the launch of its next generation technology platform Ilesto DX.

Subscribe Now